Mechanistic Modeling workshop reports: Ophthalmic, nasal, injectable, and implant generic drug products https://t.co/2ATKNqn3Xs Drug products applied to the skin https://t.co/IRt28uWNLi Generic orally inhaled drug products https://t.co/1qmFU4Uk7U
Mechanistic modeling of drug products applied to the skin: A workshop summary report.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2023 – Aug 2023Where it's discussed
-
X / Twitter1 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions express a moderate consensus on the value of mechanistic modeling in improving drug development, with posts mentioning workshops on various drug forms like ophthalmic and nasal products, and emphasizing the potential for advancing generic skin treatments. The tone reflects cautious optimism, highlighting the significance of these methods for future pharmaceutical innovations.
Many discussions acknowledge the value of the workshop and modeling techniques, showing moderate agreement about the importance of this approach.
Posts demonstrate a general interest in the topic, especially regarding how modeling can help develop skin drugs, but some show limited enthusiasm.
Most comments remain at a surface level, referencing the workshop topics broadly without deep dives into technical details.
Participants believe the research and modeling approaches discussed could positively influence the development and approval of dermatological drugs, indicating a recognized but not overwhelming impact.
Abstract in brief
- The development of generic topical skin drugs is challenging because measuring how much of the active ingredient reaches the target area in the skin is difficult, and there is often no clear link between skin and blood drug levels.
- The FDA has initiated research programs aimed at improving access to affordable and effective dermatological generics by using modeling and simulation techniques to find new ways to demonstrate drug bioequivalence.
- This report highlights insights from a 2021 FDA workshop that discussed how mechanistic modeling can help in the development and regulatory approval process of generic skin medications.]
Top posts
Most liked on X and BlueskyAll mentions
Mechanistic Modeling for Topical Skin Drug Development and Approvals
The development of generic skin drugs is challenging due to difficulties in measuring active ingredient levels. This video summarizes insights from a 2021 FDA workshop on how mechanistic modeling aids in the development…
Mechanistic Modeling workshop reports: Ophthalmic, nasal, injectable, and implant generic drug products https://t.co/2ATKNqn3Xs Drug products applied to the skin https://t.co/IRt28uWNLi Generic orally inhaled drug products https://t.co/1qmFU4Uk7U